1. Home
  2. FNWD vs MSLE Comparison

FNWD vs MSLE Comparison

Compare FNWD & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$41.52

Market Cap

187.1M

Sector

Finance

ML Signal

N/A

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

HOLD

Current Price

$6.99

Market Cap

186.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
MSLE
Founded
1994
2018
Country
United States
Canada
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
187.1M
186.9M
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
FNWD
MSLE
Price
$41.52
$6.99
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $25.80
AVG Volume (30 Days)
7.9K
★ 57.4K
Earning Date
10-29-2026
11-15-2026
Dividend Yield
★ 1.15%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.00
N/A
Revenue
N/A
N/A
Revenue This Year
$10.81
N/A
Revenue Next Year
$5.26
N/A
P/E Ratio
$41.75
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.05
$5.44
52 Week High
$45.90
$13.39

Technical Indicators

Market Signals
Indicator
FNWD
MSLE
Relative Strength Index (RSI) 42.61 26.35
Support Level $34.83 $6.71
Resistance Level $44.01 $10.58
Average True Range (ATR) 0.61 0.56
MACD -0.06 -0.15
Stochastic Oscillator 16.57 0.00

Price Performance

Historical Comparison
FNWD
MSLE

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: